Global Surgical Site Infection Control Market | Growth, Share - PowerPoint PPT Presentation

About This Presentation

Global Surgical Site Infection Control Market | Growth, Share


Global surgical site infection control (SSI) market is estimated to grow at a CAGR of 5.95%, and is expected to amount to $6969.5 million by 2028. Get free sample report. – PowerPoint PPT presentation

Number of Views:28


Transcript and Presenter's Notes

Title: Global Surgical Site Infection Control Market | Growth, Share

The Global Surgical Site Infection Control Market
to Develop at CAGR of 5.95 by 2028
  • Triton Market Research presents the Global
    Surgical Site Infection Control Market report
    segmented by Industrial Vertical (Ambulatory
    Surgical Centers, Hospitals), Procedure (Plastic
    Reconstructive Surgery, Laparoscopy, Thoracic
    Surgery, Neurosurgery, Cardiovascular, Orthopedic
    Surgery, Microvascular, Obstetrics and
    Gynecology, Urology, Wound Closure, Other
    Procedures), Product (Surgical Drapes, Surgical
    Scrubs, Manual Reprocessors Solution, Surgical
    Irrigation, Medical Nonwovens, Surgical Gloves,
    Hair Clippers, Skin Preparation Solution,
    Disinfectants Hand Disinfectants, Skin
    Disinfectants, Other Products), Type of
    Infection (Deep Incisional SSI, Organ Or Space
    SSI, Superficial Incisional SSI), and Geography
    (Asia-Pacific, North America, Middle East and
    Africa, Latin America, Europe). The report
    further discusses the Market Summary, Industry
    Outlook, Market Definition, Porter's Five Forces
    Model, Impact of COVID-19, Market Attractiveness
    Index, Vendor Scorecard, Key Insights, Drivers,
    Restraints, Opportunities, Company Profiles,
    Research Methodology Scope, Global Market Size,
    Forecasts Analysis (2021-2028).
  • Triton's report implies that the global surgical
    site infection control market is likely to
    register growth at 5.95 of CAGR during the
    estimated phase of 2021-2028.

Request free sample https//www.tritonmarketresea
rketrequest-free- sample
Surgical site infection (SSI) refers to an
infection that arises in a body part that has
undergone surgery. This infection can be deep
incisional, organ-related, or superficial. Here,
the rising hospital-acquired infections and the
growing number of surgeries are motivating the
SSI control market's growth. The growing number
of surgical procedures and surge in complications
caused by healthcare-associated infections are
the major factors opening multiple opportunities
for the studied market globally. There is a
significant rise in the prevalence of
complications of hospital-acquired infections.
Here, these infections are usually connected with
the admission of patients in a critical-care
hospital. Hence, this growth in HAIs increases
the need for measures to protect patients from
getting severely infected. However, the growing
use of outpatient procedures and surged usage of
disposable medical products are hampering the
surgical site infection control market's
progress. North America holds the largest share
in the surgical site infection control market,
and is likely to maintain its hold over the
market till 2028. The region's market is mainly
motivated by the rising risk of infection among
the population. Moreover, the recent pandemic
outbreak has surged the risk of spreading the
COVID-19 infection, which is also likely to drive
the studied market's progress in the next few
years. Further, there is tremendous growth in the
number of cataract surgery in the region. For
instance, there are around three million people
each year in the United States that undergo
cataracts surgery. This further motivates the
growth of the surgical site infection control
market across North America. The prominent
companies thriving in this market include
American Polyfilm, 3M Company, Steris
Corporation, Gama Healthcare, Becton Dickinson
and Company (BD), Johnson Johnson, Pacon
Manufacturing Corporation, Biomerieux SA,
Kimberly Clark, Lac-Mac, Stryker Corporation,
Getinge AB, Ansell Ltd, Sotera Health LLC, and
Belimed AG. In the market, the threat of new
players is anticipated to be relatively high,
owing to the rising acceptance and clearances by
the FDA for surgical products. For instance,
surgical masks are used as protective gear for
surgeons from airborne particles and other
contaminants. Simultaneously, the competition
among the current players is projected to be
moderate to a high level due to the high
sustainable competitive advantage gained by
players via innovation.
Contact Us
Phone 44 7441 911839
Write a Comment
User Comments (0)